TELO CIK: 1971532

Telomir Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
0.05
FY23:
0.44
FY24:
1.32
FY25:
7.34
(positive)
millions USD
FY22:
0
FY23:
4.34
FY24:
0
FY25:
0
Total assets
Change from FY22 to FY25
millions USD
FY22:
0.05
FY23:
4.77
FY24:
1.32
FY25:
7.34

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
0.99
FY23:
1.34
FY24:
0.68
FY25:
1.43
(negative)
millions USD
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY22:
−0.94
FY23:
3.44
FY24:
0.64
FY25:
5.91
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
0.05
FY23:
4.77
FY24:
1.32
FY25:
7.34

All amounts in millions USD Data sources:SEC EDGARTwelve Data